Cannabidiol

WEED Australia Ltd is Proud to Announce the Appointment of Ms. Amanda Brunskill-Scott and Mrs. Nicole Breen as Members of our Board of Directors

Retrieved on: 
Wednesday, May 17, 2023
IPO, Gold Coast, Cannabaceae, Pharmacy, Perception, COVID-19, Mexican Cannabis Institute, OTCQB, ASX, Research, Risk, COVID, Accounting, C.I.A, Pithing, Corporation, Health, Cannabidiol, THC, Family, News, PTSD, ASIC, Management, Medicinal plants, Drug, Agriculture, Pharmaceutical industry, Financial adviser, CBD, Cannabis

In addition, Ms. Brunskill-Scott has been appointed as our in-house counsel for both WEED Australia Limited and the Cannabis Institute of Australia.

Key Points: 
  • In addition, Ms. Brunskill-Scott has been appointed as our in-house counsel for both WEED Australia Limited and the Cannabis Institute of Australia.
  • I am excited to work with Amanda and bring WEED Australia to its full potential in the cannabis and hemp space.
  • WEED Australia Ltd. formed in March 2017 was the first cannabis pubco, ASIC regulated, in Australia with an American parent.
  • WEED Hong Kong Ltd. Director Nicole Breen agrees, "The pandemic has affected all of us on a worldwide basis.

Pet CBD Club Announces New Line of CBD Products for Cats and Dogs, Designed to Promote Pet Well-Being

Retrieved on: 
Friday, May 12, 2023
Human, Dog, Anxiety, Quality of life, Cat, Pain, Animal, Pet, Happiness, CBD, Research, Health, Cannabidiol, Pet industry

Mayville, North Dakota--(Newsfile Corp. - May 12, 2023) - Pet CBD Club , a leading provider of CBD products for pets, is excited to announce the launch of their new line of CBD products specifically formulated for cats and dogs.

Key Points: 
  • Mayville, North Dakota--(Newsfile Corp. - May 12, 2023) - Pet CBD Club , a leading provider of CBD products for pets, is excited to announce the launch of their new line of CBD products specifically formulated for cats and dogs.
  • The new products, CBD For Cats and CBD For Dogs, are designed to promote overall pet health and well-being.
  • By offering high-quality CBD products, Pet CBD Club aims to help pets live their best lives, free from anxiety, pain, and other common issues that can affect their overall health and happiness.
  • The CBD For Cats and CBD For Dogs products offered by Pet CBD Club are formulated with the highest quality, organically grown hemp-derived CBD.

Global Cannabis Testing Market Report 2023: Rising Number of Advanced Laboratories Drive Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 11, 2023
Cannabis, Natural Resources, Seizure, Glaucoma, Mycotoxin, Migraine, Employment, Seed, Anxiety, Research, Inflammation, Pain, CBN, Solvent, Pesticide, Cannabinol, Soil, Laboratory, Nausea, Growth, LIMS, THC, Smoking, Chronic pain, Insecticide, Disease, Drug, Cannabidiol, CBD

Cannabis, also known as marijuana, is obtained from the dried flowers, leaves, stems, and seeds of the Cannabis sativa or Cannabis indica plant.

Key Points: 
  • Cannabis, also known as marijuana, is obtained from the dried flowers, leaves, stems, and seeds of the Cannabis sativa or Cannabis indica plant.
  • In line with this, the growing number of advanced laboratories to conduct cannabis testing is presently offering a favorable market outlook.
  • Besides this, the rising legalization of medical cannabis to treat various diseases is offering lucrative growth opportunities to industry investors.
  • Moreover, the increasing awareness among the masses about the benefits of cannabis testing through conferences, symposia, and workshops is propelling the growth of the market.

22nd Century Group (Nasdaq: XXII) Reports First Quarter 2023 Financial Results, Introduces 2023 Full Year Revenue Outlook

Retrieved on: 
Tuesday, May 9, 2023
Acceleration, Nonmotorized Transportation Pilot Program, Nicotine, Table, Q&A, Casualty loss, GVB, Policy, Tobacco, CMO, Pacific Century Group, CBG, Sale, Old pal, EBITDA, CDMO, Acquisition, Investment, Pinnacle, Smoke, NASCO, XXII, Growth, Webcast, FSA, Century, Health, FDA, Smoking, Biomass, Adjustment, Cannabidiol, Geography, Real estate, Video game, Beauty salon, Management, Drug, Retail, Oil, EU, CBD

We again reported record cannabinoid ingredient volumes delivered in the first quarter, a trend we expect to further increase throughout 2023.

Key Points: 
  • We again reported record cannabinoid ingredient volumes delivered in the first quarter, a trend we expect to further increase throughout 2023.
  • “We believe 22nd Century is poised for phenomenal growth this year in both our tobacco and hemp/cannabis businesses.
  • Operating loss for the first quarter of 2023 was $17.8 million, compared to $8.1 million in the prior year period.
  • During the webcast, James A. Mish, chief executive officer of 22nd Century Group, John Miller, president of 22nd Century’s tobacco business, and Hugh Kinsman, chief financial officer, will provide an update on the Company.

Incannex Announces Final Results from Phase 1 Clinical Trial Assessing Safety and Pharmacokinetics of IHL-675A

Retrieved on: 
Tuesday, May 2, 2023
Tmax, Comparison, Half-life, Somnolence, Pharmacokinetics, ASX, Cmax, Inflammation, Abdominal pain, HCQ, Inflammatory bowel disease, Plasma, Defecation, Incidence, Dizziness, Appendix, Headache, Safety, Rheumatoid arthritis, Fatigue, Pharmaceutical industry, Hydroxychloroquine, Cannabidiol, CBD

The Phase 1 trial measured the safety, tolerability, and pharmacokinetic profiles of IHL-675A compared to the reference listed drugs, Epidiolex (CBD) and Plaquenil (HCQ).

Key Points: 
  • The Phase 1 trial measured the safety, tolerability, and pharmacokinetic profiles of IHL-675A compared to the reference listed drugs, Epidiolex (CBD) and Plaquenil (HCQ).
  • Three cohorts of 12 participants (n = 36) received either IHL-675A, CBD or HCQ and the clinical assessments were identical across the three arms of the trial.
  • The trial was conducted by CMAX Clinical Research in Adelaide, South Australia and managed by Avance Clinical.
  • Incannex Chief Scientific Officer Dr Mark Bleackley said: “The results from the Phase 1 trial are a critical milestone in the development of IHL-675A.

Charlotte's Web Expands Distribution with America's Largest National Distributor in Pet Specialty, Phillips Pet Food & Supplies

Retrieved on: 
Monday, May 1, 2023
Charlotte's Web, TSX, Phillips, Cognition, CWEB, Cannabidiol, Ultrasound-guided hip joint injection, CBD

LOUISVILLE, Colo., May 1, 2023 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in cannabidiol ("CBD") hemp extract wellness products is pleased to add Phillips Pet Food & Supplies ("Phillips"), America's largest distributor in the pet specialty retail channel, covering more than 6,000 retailers representing more than 14,000 retail locations.

Key Points: 
  • LOUISVILLE, Colo., May 1, 2023 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in cannabidiol ("CBD") hemp extract wellness products is pleased to add Phillips Pet Food & Supplies ("Phillips"), America's largest distributor in the pet specialty retail channel, covering more than 6,000 retailers representing more than 14,000 retail locations.
  • Phillips boasts a broad assortment of pet specialty retail, paired with comprehensive customer touchpoints to drive engagement across its national footprint from independent boutique pet stores to regional chains and national chains and mass retailers.
  • Initial orders have been shipped and Phillips will distribute the full line of Charlotte's Web pet products, including topical pet products, and functionally focused CBD dog chews with synergistic ingredients to support specific health functions; Calming, Hips & Joints, and Cognition.
  • "We are thrilled to have Phillips as our national distribution partner for pet products.

Aurora Expands Medical Cannabis Portfolio in Germany: New flower varieties for patients with high THC needs

Retrieved on: 
Friday, April 28, 2023
Aurora, SRD, AB, FRG, Patient, Physician, ACB, Cannabis, TSX, THC, Cannabidiol, Medicinal plants, CBD

Pedanios 27/1 FRG CA and Pedanios 29/1 SRD CA are dried cannabis flower with high tetrahydrocannabinol (THC) content.

Key Points: 
  • Pedanios 27/1 FRG CA and Pedanios 29/1 SRD CA are dried cannabis flower with high tetrahydrocannabinol (THC) content.
  • With these new therapeutic options now available, the Company will better meet the individual medical needs of its patients.
  • "We are committed to bringing high quality, consistent and innovative cannabis products to our patients in Germany and throughout Europe."
  • Pedanios 29/1 SRD CA is medical cannabis flower from the Sourdough cultivar, with approximately 29% THC and

Charlotte's Web Q1-2023 Earnings Call and Webcast Notice

Retrieved on: 
Friday, April 28, 2023
Charlotte's Web, TSX, CWEB, News, Cannabidiol, ID, CBD

A conference call to discuss the results is scheduled for the same day at 10:00 a.m. Eastern Time.

Key Points: 
  • A conference call to discuss the results is scheduled for the same day at 10:00 a.m. Eastern Time.
  • To listen to a replay of the earnings call please dial 1-416-764-8677 or 1-888-390-0541 and provide conference replay ID 487501.
  • A webcast of the call will also be accessible through the investor relations section of the Company's website for an extended period of time.
  • Subscribe to Charlotte's Web investor news.

TIPS FROM HEMP PROS ON SURVIVING UNCERTAIN TIMES

Retrieved on: 
Thursday, April 27, 2023
Learning, Education, White paper, Delta, CO, News, H&C Communications, CBD, Cannabidiol

Denver, CO, April 27, 2023 (GLOBE NEWSWIRE) -- Hemp pros from around the country answer the question, How do you make the most of your message in uncertain times?, in M&C Communication's NoCo 2023 White Paper.

Key Points: 
  • Denver, CO, April 27, 2023 (GLOBE NEWSWIRE) -- Hemp pros from around the country answer the question, How do you make the most of your message in uncertain times?, in M&C Communication's NoCo 2023 White Paper.
  • Industry thought leaders with hemp, cannabidiol, and Delta 8 companies share tips you can act on today to protect your brand during uncertain times.
  • M&C Communications interviewed more than a dozen industry thought leaders at the 9th Annual NoCo Hemp Expo in Colorado Springs.
  • The company leaders agreed industry brands will need a strong foundation and a multi-pronged plan to succeed in this still-emerging industry.

NEURELIS ANNOUNCES FOUR POSTER PRESENTATIONS AT THE 75TH ANNUAL MEETING OF THE AMERICAN ACADEMY OF NEUROLOGY

Retrieved on: 
Tuesday, April 25, 2023
Epilepsy, Seizure, Medical Affairs Bureau, PM, Hospital, Safety, AAN, Cannabidiol, Quality of life, American Academy, Gustav Neuring, Research, Quality, ASDS, Organization, Cluster, Incidence, Long-term video-EEG monitoring, Diazepam, Poster, Patient, Physician, SAN, Effectiveness, Social, FDA, Interval, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Treatment, Food, SLC6A1 epileptic encephalopathy, Pharmaceutical industry, Nursing, CBD

These presentations will highlight quality of life, safety of concomitant cannabidiol (CBD) usage, time to treatment, and significant changes in SEIzure InterVAL (SEIVAL).

Key Points: 
  • These presentations will highlight quality of life, safety of concomitant cannabidiol (CBD) usage, time to treatment, and significant changes in SEIzure InterVAL (SEIVAL).
  • The posters will be presented at the 75th Annual Meeting of the American Academy of Neurology (AAN) in Boston, April 22 to 27, in a hybrid format, with participants joining in person, or live online.
  • "Expanding the clinical profile of VALTOCO is integral to our commitment to improve outcomes for patients with seizure clusters," said Enrique Carrazana, M.D., Neurelis Chief Medical Officer.
  • Details of the selected poster presentations are below and available online to review at the American Academy of Neurology Annual Meeting website:
    SEIzure InterVAL (SEIVAL) Between Seizure Clusters and Quality of Life Across Time From a Phase 3 Safety Study of Diazepam Nasal Spray for Seizure Clusters ; Poster #002, Tuesday, April 25th, 5:30 PM - 6:30 PM ET.